Staying Expedited Proceedings - Neurim Pharmaceuticals v Mylan
.jpg)
Author Karjis Sambrans Licence CC BY 2.0 Source Wikimedia Common s Jane Lambert Patents Court (Mr Ian Karet) Neurim Pharmaceuticals (1991) Ltd another v Generics (UK) Ltd (T/A Viatris) and another [2021] EWHC 2897 (Pat) (29 Ort 2021) This was an application by Generics (UK) Limited and Mylan UK Healthcare Limited ("Mylan") for a stay of the expedited trial that had been ordered by Mr Justice Mellor in Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2021] EWHC 2198 (Pat) (2 Aug 2021) which I discussed in Practice - Neurim Pharmaceuticals v Mylan on 30 March 2022. The purpose of the proposed stay was to await the outcome of opposition proceedings in the European Patent Office under Part V of the European Patent Convention. The outcome of those proceedings including an appeal could be expected in 2023 or 2024. The reason why Mr Justice Mellor ordered an expedited trial is that Eur...